Refactor Capital is a seed stage VC firm investing in bio, climate, and health.
Refactor Capital is a seed-stage VC firm investing in bio, climate, and health. We aim to help create a happier, healthier, and more habitable world via software, technology, and the power of biology. Refactor typically leads or co-leads seed and pre-seed rounds with $1-2M checks.
Date
Company Name
|
Round | Money Raised | Industry | Lead Investor |
---|---|---|---|---|
Sep 23, 2020
Curative
|
Seed | $8M | Health Care | — |
Mar 27, 2020
Avail Medsystems
|
Series A | $15M | Clinical Trials | — |
Jan 1, 2019
AKASA
|
Seed | $5M | Artificial Intelligence | — |
Oct 10, 2018
Blockfolio
|
Series A | $11.50M | Bitcoin | — |
Apr 30, 2018
Biobot Analytics
|
Seed | $2.50M | Analytics | — |